We are live on ! Find out more
BC

Blackhill Capital Portfolio holdings

AUM $1.94B
1-Year Est. Return 18.09%
This Fund
S&P 500
This Quarter Est. Return
+12.13%
1 Year Est. Return
+18.09%
3 Year Est. Return
+164.47%
5 Year Est. Return
+136.25%
10 Year Est. Return
+688.12%
AUM
$829M
AUM Growth
+$89.4M
Cap. Flow
+$6.36M
Cap. Flow %
0.77%
Top 10 Hldgs %
82.19%
Holding
59
New
3
Increased
8
Reduced
8
Closed
1

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$3.59M
2
ELAN icon
Elanco Animal Health
ELAN
+$3.26M
3
WSM icon
Williams-Sonoma
WSM
+$894K
4
VTRS icon
Viatris
VTRS
+$800K
5
KRON
Kronos Bio
KRON
+$267K

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$981K
2
PFE icon
Pfizer
PFE
+$791K
3
PM icon
Philip Morris
PM
+$389K
4
ZBH icon
Zimmer Biomet
ZBH
+$196K
5
ZTS icon
Zoetis
ZTS
+$97.6K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 49.99%
2 Healthcare 32.03%
3 Technology 6.33%
4 Communication Services 4.6%
5 Consumer Staples 2.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MMP
26
DELISTED
Magellan Midstream Partners, L.P.
MMP
$2.33M 0.28%
54,800
– –
BRK.A icon
27
Berkshire Hathaway Class A
BRK.A
$1.11T
$2.09M 0.25%
6
– –
GOOG icon
28
Alphabet (Google) Class C
GOOG
$4.19T
$1.55M 0.19%
17,660
– –
RMD icon
29
ResMed
RMD
$32.6B
$1.53M 0.18%
7,200
– –
GOOGL icon
30
Alphabet (Google) Class A
GOOGL
$4.2T
$1.4M 0.17%
15,980
+560
+4% +$47.1K
WTRG icon
31
Essential Utilities
WTRG
$11.4B
$1.23M 0.15%
26,041
– –
CVX icon
32
Chevron
CVX
$386B
$975K 0.12%
11,550
– –
AWK icon
33
American Water Works
AWK
$27B
$921K 0.11%
6,000
– –
VTRS icon
34
Viatris
VTRS
$18.7B
$919K 0.11%
+49,052
New +$800K
WY icon
35
Weyerhaeuser
WY
$18B
$880K 0.11%
26,240
– –
AWR icon
36
American States Water
AWR
$3.47B
$859K 0.1%
10,800
– –
MGNI icon
37
Magnite
MGNI
$3.49B
$848K 0.1%
27,615
– –
MCD icon
38
McDonald's
MCD
$194B
$644K 0.08%
3,000
– –
VFC icon
39
VF Corp
VFC
$5.81B
$615K 0.07%
7,200
– –
MSEX icon
40
Middlesex Water
MSEX
$1.1B
$483K 0.06%
6,666
– –
PM icon
41
Philip Morris
PM
$290B
$431K 0.05%
5,200
-5,000
-49% -$389K
CL icon
42
Colgate-Palmolive
CL
$73.6B
$428K 0.05%
5,000
– –
PCH
43
DELISTED
PotlatchDeltic
PCH
$427K 0.05%
8,540
– –
CWT icon
44
California Water Service
CWT
$3.09B
$411K 0.05%
7,600
– –
AVNS
45
DELISTED
Avanos Medical
AVNS
$341K 0.04%
7,436
-475
-6% -$19.8K
FFIV icon
46
F5
FFIV
$23.4B
$284K 0.03%
1,614
– –
KRON
47
DELISTED
Kronos Bio
KRON
$254K 0.03%
+8,500
New +$267K
SPY icon
48
State Street SPDR S&P 500 ETF Trust
SPY
$807B
$246K 0.03%
658
– –
RYN icon
49
Rayonier
RYN
$6.45B
$242K 0.03%
9,093
– –
IDXX icon
50
Idexx Laboratories
IDXX
$46.2B
$200K 0.02%
400
-200
-33% -$89.5K
1
2
3

Similar funds

FFH
Fairfax Financial Holdings Toronto, Ontario, Canada $1.94B AUM 27.76% 1-Year Est. Return
OCM
Osterweis Capital Management San Francisco, California $1.94B AUM 20.77% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
HC
Hamilton Capital Columbus, Ohio $1.93B AUM
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return

Blackhill Capital's Q4 2020 Portfolio in Review

As of Q4 2020, Blackhill Capital held 59 positions worth $829M, up 12% from $740M the previous quarter. Its ten largest holdings account for 82% of the portfolio.

Blackhill Capital's Q4 2020 filing shows 3 new, 8 increased, 8 reduced and 1 closed positions. Its largest new stake was Viatris: 49,052 shares worth $919K. The largest sale was Eli Lilly, an estimated $981K.

By sector, the portfolio is most concentrated in Consumer Discretionary at 50% of assets, up from 50% a quarter earlier, followed by Healthcare and Technology.

  • Blackhill Capital's largest Q4 2020 buy was Viatris: 49,052 shares worth $919K.
  • Blackhill Capital added most to Merck in Q4 2020, an estimated $3.59M increase.
  • Blackhill Capital's biggest Q4 2020 reduction was Eli Lilly, cutting an estimated $981K.
  • Blackhill Capital fully exited Bristol-Myers Squibb Company Contingent Value Rights in Q4 2020, selling an estimated $63K.
  • Blackhill Capital's ten largest holdings make up 82% of its $829M portfolio in Q4 2020.
  • Blackhill Capital opened 3 new positions and closed 1 in Q4 2020.
  • Blackhill Capital's portfolio value rose 12% quarter-over-quarter to $829M.

Based on Blackhill Capital's 13F filing for Q4 2020, filed 8 Feb 2021.